| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02169141 | Tuberculosis | Other: Pharmacokinetics | University Medical Center Groningen|Republican Scientific and Practical Centre for Pulmonology and TB|National Institute for Public Health and the Environment (RIVM) | 2012-11-01 | 2014-06-20 |
| NCT02236078 | Tuberculosis|Drug-resistant Tuberculosis|Multidrug-resistant Tuberculosis | Drug: Capreomycin|Drug: High dose isoniazid|Drug: Rifampicin|Drug: Rifabutin|Drug: Moxifloxacin | Centers for Disease Control and Prevention|Kenya Medical Research Institute | | 2015-11-01 | 2016-07-25 |
| NCT01464762 | Tuberculosis | Drug: TMC207 | Janssen Infectious Diseases BVBA | | null | 2017-01-30 |
| NCT00000796 | HIV Infections|Tuberculosis | Drug: Cycloserine|Drug: Ethionamide|Drug: Capreomycin sulfate|Drug: Aminosalicylic acid|Drug: Streptomycin sulfate|Drug: Ethambutol hydrochloride|Drug: Amikacin sulfate|Drug: Isoniazid|Drug: Pyrazinamide|Drug: Pyridoxine hydrochloride|Drug: Levofloxacin|Drug: Rifampin|Drug: Clofazimine | National Institute of Allergy and Infectious Diseases (NIAID) | | null | 2012-03-30 |
| NCT02496572 | Multidrug Resistant Tuberculosis | Drug: Short course MDR-TB treatment regimen | Medecins Sans Frontieres, Netherlands|Ministry of Health, Republic of Uzbekistan|Imperial College London | Phase 3 | 2013-09-01 | 2015-07-09 |
| NCT00042289 | HIV Infections | Drug: atazanavir/cobicistat|Drug: darunavir/ritonavir|Drug: darunavir/cobicistat|Drug: etravirine|Drug: elvitegravir/cobicistat|Drug: dolutegravir|Drug: tenofovir alafenamide fumarate (TAF)|Drug: TAF/cobicistat|Drug: TAF/ritonavir|Drug: efavirenz|Drug: lopinavir/ritonavir|Drug: nevirapine|Drug: rifampicin|Drug: ethambutol|Drug: isoniazid|Drug: pyrazinamide|Drug: rifampicin|Drug: kanamycin|Drug: amikacin|Drug: capreomycin|Drug: moxifloxacin|Drug: levofloxacin|Drug: ofloxacin|Drug: ethionamide/prothionamide|Drug: terizidone/cycloserine|Drug: para-aminosalicylic acid (PAS)|Drug: high dose isoniazid (INH)|Drug: bedaquiline|Drug: clofazamine|Drug: delamanid|Drug: linezolid|Drug: pretomanid|Drug: atazanavir/ritonavir/tenofovir|Drug: ethinyl estradiol oral contraceptive|Drug: etonogestrel implant | National Institute of Allergy and Infectious Diseases (NIAID)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 | 2003-03-01 | 2017-03-13 |
| NCT02099240 | Osteomyelitis | Drug: oral antibiotics|Procedure: intravenous antibiotics | Julio Ramirez|James Graham Brown Cancer Center|University of Louisville | Early Phase 1 | 2014-04-01 | 2017-03-21 |
